Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples